First-to-market cell line-derived reference standard for myeloid blood cancers Largest cell-line derived reference standard available, contains 22 mutations across 19 oncology-relevant genes Enables faster, more reliable and more cost-effective assay validation Cambridge, UK: Horizon Discovery Group plc (LSE: HZD) (“Horizon” or “the Company”), a global leader in gene editing and gene modulation technologies, today announced the […]

HAYWARD, Calif.–Mawi DNA Technologies, a biotechnology company focusing on the development of innovative technologies for biosampling, announces the launch of iSWAB-Cells. Designed to collect and stabilize intact cells for up to four weeks at room temperature, the sample collection system enables researchers to perform multiple OMICS analyses from the same sample. The iSWAB-Cells family of […]

Malvern PA. A new cell based profiling service for drug discovery announced by Reaction Biology Corporation (RBC), a premier provider of drug discovery services, and Promega Corporation, a worldwide leader in the supply of life science products, will allow more researchers to better prioritize compounds earlier. Based on Promega NanoBRETTM technology, the service measures direct […]

MENLO PARK, Calif. — Akoya Biosciences, a private biotech start-up, announced today that VIB, a leading life sciences institute in Belgium, will be one of its first partners for exploring the CODEX™ (CO-Detection by indexing) technology in Europe. The CODEX™ technology originates from Dr. Garry Nolan’s lab at Stanford University and is the only technology available to provide spatial and quantitative analysis of up to […]

We are excited to announce the release of the new 1.3.0 version of NovoExpress® software which  supports  the recently launched NovoCyte QuanteonTM flow cytometers and  NovoSampler® Q autosampler products, in addition to NovoCyte® flow cytometer and NovoSampler® Pro products. In addition to the functionalities supporting the expanded flow cytometer products for data acquisition, this version of NovoExpress also implements a variety […]

IsoPlexis’ groundbreaking platform has been shown in key studies to predict patient response to cell therapy BRANFORD, Conn. — The IsoLight® platform: profiles responses at the single cell level enabling researchers to generate a precise functional patient signature to help predict and understand complex patient response to cancer immunotherapies advances high-need areas of cell therapy research, development, and manufacturing, including product characterization, immune biomarker discovery, […]

RESEARCH TRIANGLE PARK, N.C.–Cell Microsystems, a provider of innovative tools and scalable solutions for the sorting and isolation of single cells, announced today that James Kane has joined the Company as Director of Sales. Mr. Kane will lead the commercial activity at Cell Microsystems for all Engineered and Array Products, bringing a depth of experience […]

RESEARCH TRIANGLE PARK, N.C.–Cell Microsystems, a provider of innovative tools and scalable solutions for the sorting and isolation of single cells, announced today that James Kane has joined the Company as Director of Sales. Mr. Kane will lead the commercial activity at Cell Microsystems for all Engineered and Array Products, bringing a depth of experience […]

* Dale Gordon, former executive of GE Healthcare Life Sciences, joins as CEO New York, New York and West Sacramento, CA –  Gemini Bioproducts, LLC (“Gemini” or the “Company”), a portfolio company of BelHealth Investment Partners, LLC (“BelHealth”), a New York-based healthcare private equity firm, announced the appointment of Dale Gordon as Chief Executive Officer […]

Stream Bio Ltd, a company that develops and manufactures a range of revolutionary bioimaging molecular probes, has today launched its transformative Conjugated Polymer Nanoparticle (CPN™) products with life science distributors 2BScientific. Current bioimaging products have weak fluorescence and low sensitivities, which often fade prematurely. Stream Bio’s non-toxic molecular bioimaging probes, known as CPNs™, are set […]